English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  53252725    Online Users :  655
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"shan ys"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 1-50 of 133  (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2025-09-01 Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study-TCOG T1214 study Tsai, HJ;Chen, MH;Wang, HP;Hsiao, CF;Chen, YY;Chen, JS;Yang, MD;Tzen, CY;Shan, YS;Bai, LY;Chan, DC;Chu, PY;Ho, CL;Yang, Y;Lin, J;Lin, HY;Chang, CS;Wang, CC;Hwang, TL;Chen, LT
國家衛生研究院 2025-07-07 Arid1a deficiency sensitises pancreatic cancer to fatty acid synthase inhibition Kuo, TL;Hou, YC;Shan, YS;Chen, LT;Hung, WC
國家衛生研究院 2025-07 5-FU+Nal-IRI vs FOLFOX/XELOX as second-line treatment for patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) after gemcitabine and nab-paclitaxel (GemNab): A propensity score-matched analysis Trovato, G;Rossini, D;Su, YY;Shan, YS;Chou, WC;Bagala, C;Bensi, M;Niger, M;Marchesi, S;Garattini, SK;Michelotti, A;Chiang, NJ;Pretta, A;Scartozzi, M;Vivaldi, C;Bartalini, L;Procaccio, L;Chen, LT;Tortora, G;Salvatore, L
國家衛生研究院 2025-05-29 Macrophage activation determines muscle wasting in pancreatic cancer Chang, CJ;Huang, PH;Chen, SY;Su, PC;Ding, LY;Hou, YC;Hung, MN;Chen, KL;Wu, YN;Wu, SR;Lin, FC;Lu, PJ;Wu, HY;Chen, YJ;Chang, CH;Chang, CP;Hwang, DY;Wang, YC;Shan, YS
國家衛生研究院 2025-04-22 Phase I study of oral metronomic gemcitabine (D07001) in patients with advanced solid tumors Chiang, NJ;Lee, JH;Chen, MH;Chao, Y;Su, WC;Bai, LY;Wu, SY;Hsu, CH;Shan, YS;Li, CP;Chen, SH;Chung, WP;Hao, WH;Chen, LT;Lin, CC
國家衛生研究院 2025-03 Single-cell RNA sequencing via endoscopic ultrasound-guided fine-needle biopsy for pancreatic tumors uncovered an aggressive subclone with a poor prognosis Su, YY;Lin, MY;Cheng, SM;Chang, WL;Hsu, CW;Yeh, CM;Yu, CC;Hou, YC;Huang, CJ;Liu, YS;Chao, YJ;Wang, DY;Shan, YS;Chen, LC
國家衛生研究院 2025-01-18 Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells Wang, CA;Hou, YC;Hong, YK;Tai, YJ;Shen, CH;Hou, PC;Fu, JL;Wu, CL;Cheng, SM;Hwang, DY;Su, YY;Shan, YS;Tsai, SJ
國家衛生研究院 2024-09 TCOG T5221 trial: A phase II randomized study of gemcitabine and nab-paclitaxel in combination with S-1/LV (GASL) or oxaliplatin (GAP) as first-line treatment for metastatic pancreatic cancer Su, YY;Bai, LY;Huang, CJ;Chiu, CF;Wang, HT;Du, JS;Wang, HC;Chuang, S;Shih, YH;Lin, HC;Shan, YS;Chen, LT
國家衛生研究院 2024-07-11 Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: A nationwide registry study Tsai, HJ;Shan, YS;Yang, CY;Hsiao, CF;Tsai, CH;Wang, CC;Lin, MT;Ting, CF;Chan, DC;Chen, TH;Yen, CC;Chen, YY;Lin, HY;Yeh, TS;Ho, CL;Shieh, TY;Bai, LY;Hsu, JT;Chen, IS;Chen, LT;Yeh, CN;Liu, TW;Chuang, CH;Wang, TE
國家衛生研究院 2024-06-21 A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study Tsai, HJ;Yang, SH;Hsiao, CF;Kao, HF;Su, YY;Shan, YS;Yen, CJ;Du, JS;Hsu, C;Wu, IC;Chen, LT
國家衛生研究院 2024-03-25 Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer Tang, CY;Yang, SH;Li, CP;Su, YY;Chiu, SC;Bai, LY;Shan, YS;Chen, LT;Chuang, SC;Chan, DC;Yen, CJ;Peng, CM;Chiu, TJ;Chen, YY;Chen, JS;Chiang, NJ;Chou, WC
國家衛生研究院 2024-02-13 Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: A multicenter study in Taiwan Cheng, SM;Su, YY;Chiang, NJ;Wang, CJ;Chao, YJ;Huang, CJ;Tsai, HJ;Chen, SH;Chang, CY;Tsai, CR;Li, YJ;Yen, CJ;Chuang, SC;Chang, JSM;Shan, YS;Hwang, DY;Chen, LT
國家衛生研究院 2023-Auh-15 Pancreatic cancer cell-derived semaphorin 3A promotes neuron recruitment to accelerate tumor growth and dissemination Hung, YH;Hou, YC;Hsu, SH;Wang, LY;Tsai, YL;Shan, YS;Su, YY;Hung, WC;Chen, LT
國家衛生研究院 2023-11 Single-cell RNA sequencing via Endoscopic Ultrasoundguided Fine-Needle Biopsy (EUS-FNB) Pancreatic Biopsies uncovered an aggressive subclone with a poor prognosis Su, YY;Lin, MY;Cheng, SM;Chang, WL;Yeh, CM;Yu, CC;Hsu, CW;Shan, YS;Huang, DY;Chen, LT
國家衛生研究院 2023-07-04 The impact of preoperative waiting time in Stage II-III gastric or gastroesophageal junction cancer: A population-based cohort study Yen, CC;Yang, YH;Ku, HY;Hu, HM;Lo, SS;Chang, HC;Chao, Y;Chen, JS;Wang, HP;Wang, TE;Bai, LY;Wu, MS;Yen, CJ;Chen, LT;Shan, YS
國家衛生研究院 2023-06-08 The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer. a cross sectional study Su, YY;Chao, YJ;Wang, CJ;Liao, TK;Su, PJ;Huang, CJ;Chiang, NJ;Yu, YT;Tsai, HM;Chen, LT;Shan, YS
國家衛生研究院 2023-06 Phase 1 studies of D07001-F4 and D07001-softgel capsule: Oral metronomic gemcitabine in subjects with advanced solid tumors Lin, CC;Chiang, NJ;Lee, JH;Chen, MH;Chao, Y;Su, WC;Bai, LY;Wu, SY;Hsu, CH;Shan, YS;Li, CP;Chen, SH;Chung, WP;Chen, LT
國家衛生研究院 2023-04-11 Carbohydrate antigen 19-9 response to initial adjuvant chemotherapy predicts survival and failure pattern of resected pancreatic adenocarcinoma but not which patients are suited for additional adjuvant chemoradiation therapy: From a prospective randomized Chiu, YF;Liu, TW;Shan, YS;Chen, JS;Li, CP;Ho, CL;Hsieh, RK;Hwang, TL;Chen, LT;Ch'ang, HJ; Taiwan Cooperative Oncology Group pancreatic cancer study group,
國家衛生研究院 2023-02-05 Real-world data validation of NAPOLI-1 nomogram for the prediction of overall survival in metastatic pancreatic cancer Su, YY;Chiang, NJ;Yang, YH;Yen, CJ;Bai, LY;Chiu, CF;Chuang, SC;Yang, SH;Chou, WC;Chen, JS;Chiu, TJ;Chen, YY;Chan, DC;Peng, CM;Chiu, SC;Li, CP;Shan, YS;Chen, LT
國家衛生研究院 2023-02 The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan Su, YY;Chiang, NJ;Chang, JS;Wang, YW;Shen, BN;Li, YJ;Hwang, DY;Shan, YS;Chen, LT
國家衛生研究院 2022-12-15 An integrated microfluidic system for cholangiocarcinoma diagnosis from bile by using specific affinity probes Lu, TH;Chiang, NJ;Tsai, YC;Gopinathan, P;Huang, CJ;Chang, JL;Tu, HC;Shan, YS;Hung, SC;Lee, GB
國家衛生研究院 2022-11-15 The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinoma Chiang, NJ;Shan, YS;Li, CP;Yang, SH;Su, YY;Chiu, SC;Bai, LY;Chuang, SC;Chan, DC;Yen, CJ;Peng, CM;Chiu, TJ;Chen, YY;Chen, JS;Chou, WC
國家衛生研究院 2022-11-06 PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation Chang, TM;Chu, PY;Lin, HY;Huang, KW;Hung, WC;Shan, YS;Chen, LT;Tsai, HJ
國家衛生研究院 2022-10 An integrated microfluidic device for automated detection of cancer cells from bile for cholangiocarcinoma prognosis Chang, JL;Tsai, YC;Chiang, NJ;Huang, CJ;Huang, YS;Hung, SC;Shan, YS;Lee, GB
國家衛生研究院 2022-09-15 Predictive value of albumin combined with neutrophil-to-lymphocyte ratio for efficacy and safety profiles in patients with pancreatic ductal adenocarcinoma receiving liposomal irinotecan plus 5-fluorouracil and leucovorin Chen, YY;Hsueh, SW;Yang, SH;Chiu, SC;Chiang, NJ;Chiu, TJ;Li, CP;Bai, LY;Chiu, CF;Chuang, SC;Shan, YS;Chan, DCA;Chen, LT;Yen, CJ;Peng, CM;Chen, JS;Chou, WC
國家衛生研究院 2022-09 A prospective phase II study of biweekly S-1, leucovorin, and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma – The Taiwan Cooperative Oncology Group T1217 study Bai, LY;Li, CP;Shan, YS;Chuang, SC;Chen, JS;Chiang, NJ;Chen, YY;Tsou, HH;Chuang, MH;Chiu, CF;Liu, TW;Chen, LT
國家衛生研究院 2022-08-19 Phosphomimetic Dicer S1016E triggers a switch to glutamine metabolism in gemcitabine-resistant pancreatic cancer Park, JM;Peng, JM;Shen, YS;Lin, CY;Hsu, TW;Su, YH;Chen, HA;Saengboonmee, C;Chang, JS;Chiu, CF;Shan, YS
國家衛生研究院 2022-07-18 Impaired chromatin remodeling predicts survival to modified gemcitabine and S-1 plus nivolumab in advanced biliary tract cancer: A phase II T1219 study Chiang, NJ;Tan, KT;Bai, LY;Hsiao, CF;Huang, CY;Hung, YP;Huang, CJ;Chen, SC;Shan, YS;Chao, Y;Huang, YH;Lee, IC;Lee, PC;Su, YY;Chen, SJ;Yeh, CN;Chen, LT;Chen, MH
國家衛生研究院 2022-07-03 The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma Chiang, NJ;Hou, YC;Tan, KT;Tsai, HW;Lin, YJ;Yeh, YC;Chen, LT;Hou, YF;Chen, MH;Shan, YS
國家衛生研究院 2022-07 Improved survival with neoadjuvant chemotherapy in stage III pancreatic cancer: A single institutional experience Ting, YL;Su, YY;Chiang, NJ;Chao, YJ;Li, YJ;Huang, CJ;Liao, TK;Su, PJ;Liu, IT;Tsai, HJ;Yen, CJ;Shan, YS;Chen, LT
國家衛生研究院 2022-07 A phase II trial of nivolumab, gemcitabine and S-1 as the frst-line treatment in patients with biliary tract cancer Chen, MH;Chiang, NJ;Bai, LY;Huang, CJ;Chen, SC;Hsiao, CF;Shan, YS;Su, YY;Chen, LT
國家衛生研究院 2022-06-26 The differential clinical impacts of cachexia and sarcopenia on the prognosis of advanced pancreatic cancer Hou, YC;Chen, CY;Huang, CJ;Wang, CJ;Chao, YJ;Chiang, NJ;Wang, HC;Tung, HL;Liu, HC;Shan, YS
國家衛生研究院 2022-06-22 Dosing pattern and early cumulative dose of liposomal irinotecan in metastatic pancreatic cancer: A real-world multicenter study Su, YY;Chiang, NJ;Li, CP;Yen, CJ;Yang, SH;Chou, WC;Chen, JS;Chiu, TJ;Chen, YY;Chuang, SC;Bai, LY;Chiu, CF;Peng, CM;Chan, DC;Chiu, SC;Yang, YH;Shan, YS;Chen, LT
國家衛生研究院 2022-06-16 Cancer-cell-derived cell-free DNA can predict distant metastasis earlier in pancreatic cancer: A prospective cohort study Huang, CJ;Huang, WY;Chen, CY;Chao, YJ;Chiang, NJ;Shan, YS
國家衛生研究院 2022-06 Comparative genomic analysis and its prognostic impact on survival between viral hepatitis-related and non-viral hepatitis intrahepatic cholangiocarcinoma Chiang, NJ;Tan, KT;Huang, CY;Chen, MH;Chiu, TJ;Shan, YS;Li, CF;Chen, LT
國家衛生研究院 2022-05-15 Improved survival with induction chemotherapy and conversion surgery in locally advanced unresectable pancreatic cancer: A single institution experience Su, YY;Ting, YL;Wang, CJ;Chao, YJ;Liao, TK;Su, PJ;Chiang, NJ;Liao, IC;Yu, YT;Liu, YS;Tsai, HM;Li, YJ;Huang, CJ;Liu, IT;Tsai, HJ;Yen, CJ;Shan, YS;Chen, LT
國家衛生研究院 2022-04-15 The impact of spleen volume on the survival of metastatic pancreatic adenocarcinoma patients receiving nanoliposomal irinotecan Yang, SH;Chiang, NJ;Chiu, SC;Chou, WC;Bai, LY;Li, CP;Su, YY;Chiu, TJ;Chuang, SC;Peng, CM;Chan, DC;Chen, JS;Yen, CJ;Chen, YY;Chiu, CF;Chen, LT;Shan, YS
國家衛生研究院 2022-02-24 Semaphorin 6C suppresses proliferation of pancreatic cancer cells via inhibition of the AKT/GSK3/beta-catenin/cyclin D1 pathway Hung, YH;Hsu, SH;Hou, YC;Chu, PY;Su, YY;Shan, YS;Hung, WC;Chen, LT
國家衛生研究院 2022-02-19 Effect of previous conventional irinotecan treatment in patients with pancreatic cancer being treated with liposomal irinotecan plus 5-fluorouracil and leucovorin Chiu, TJ;Yang, SH;Chiu, SC;Hsueh, SW;Chiang, NJ;Li, CP;Bai, LY;Cheng, FM;Chuang, SC;Shan, YS;Chan, DC;Chen, LT;Yen, CJ;Peng, CM;Su, YY;Chen, YY;Chen, JS;Chou, WC
國家衛生研究院 2022-02-01 A prospective phase II study of biweekly S-1, leucovorin and gemcitabine in elderly patients with locally advanced or metastatic pancreatic adenocarcinoma Bai, LY;Li, CP;Shan, YS;Chuang, SC;Chen, JS;Chiang, NJ;Chen, YY;Tsou, HH;Chuang, MH;Chiu, CF;Liu, TW;Chen, LT
國家衛生研究院 2021-12-17 A phase II randomised trial of induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced pancreatic cancer: the Taiwan Cooperative Oncology Group T2212 study Su, YY;Chiu, YF;Li, CP;Yang, SH;Lin, J;Lin, SJ;Chang, PY;Chiang, NJ;Shan, YS;Ch’ang, HJ;Chen, LT
國家衛生研究院 2021-11-30 Survival outcomes of management in metastatic gastric adenocarcinoma patients Hu, HM;Tsai, HJ;Ku, HY;Lo, SS;Shan, YS;Chang, HC;Chao, Y;Chen, JS;Chen, SC;Chiang, CJ;Li, AF;Wang, HP;Wang, TE;Bai, LY;Wu, MS;Chen, LT;Liu, TW;Yang, YH
國家衛生研究院 2021-11-20 Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study Chiu, TJ;Su, YY;Yang, SH;Li, CP;Bai, LY;Chiang, NJ;Chuang, SC;Shan, YS;Chan, DC;Chen, LT;Yen, CJ;Peng, CM;Chen, YY;Chen, JS;Chou, WC
國家衛生研究院 2021-11-12 The prognostic and predictive role of chromogranin a in gastroenteropancreatic neuroendocrine tumors - A single-center experience Tsai, HJ;Hsiao, CF;Chang, JS;Chen, LT;Chao, YJ;Yen, CJ;Shan, YS
國家衛生研究院 2021-11-01 Exfoliated tumor cells in bile as a promising indicator of disease status in cholangiocarcinoma Gopinathan, P;Lu, TH;Chiang, NJ;Huang, CJ;Tu, HC;Hung, SC;Shan, YS;Lee, GB
國家衛生研究院 2021-09 A phase II trial of nivolumab and gemcitabine and S-1 as the first-line treatment in patients with advanced biliary tract cancer Chiang, NJ;Bai, LY;Huang, CJ;Chen, SC;Hsiao, CF;Shan, YS;Su, YY;Chen, L;Chen, MH
國家衛生研究院 2021-07-15 No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol Shan, YS;Chen, LT;Wu, CH;Chang, YF;Lee, CT;Chiang, NJ;Chao, YJ;Yen, CJ;Tsai, HJ;Huang, HE;Tsai, CR;Weng, YL;Yang, HC;Liu, HC;Chang, JS
國家衛生研究院 2021-05 High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial Pen, SL;Shan, YS;Hsiao, CF;Liu, TW;Chen, JS;Ho, CL;Chou, WC;Hsieh, RK;Chen, LT;Ch'ang, HJ
國家衛生研究院 2021-05 TCOG T5217 trial: A phase II randomized study of SLOG versus modified FOLFIRINOX as the first-line treatment in locally advanced or metastatic pancreatic ductal adenocarcinoma Chiang, NJ;Shan, YS;Bai, LY;Li, CP;Chen, JS;Yang, SH;Kuo, YC;Chao, Y;Hsieh, YY;Kao, HF;Hsiao, CF;Chen, LT
國家衛生研究院 2021-04-12 An updated analysis of the epidemiologic trends of neuroendocrine tumors in Taiwan Chang, JS;Chen, LT;Shan, YS;Chu, PY;Tsai, CR;Tsai, HJ

Showing items 1-50 of 133  (3 Page(s) Totally)
1 2 3 > >>
View [10|25|50] records per page